Other hemorrhagic disorder due to intrinsic circulating anticoagulants, antibodies, or inhibitors
Billable / specific
D68.318 is a billable, specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes in FY2027.
Inclusion terms
Applicable to
- Antithromboplastinemia
- Antithromboplastinogenemia
- Hemorrhagic disorder due to intrinsic increase in antithrombin
- Hemorrhagic disorder due to intrinsic increase in anti-VIIIa
- Hemorrhagic disorder due to intrinsic increase in anti-IXa
- Hemorrhagic disorder due to intrinsic increase in anti-XIa
Excludes1
Not coded here — never report together with this code.
Excludes2
Not included here — may be reported together when both conditions exist.
- autoimmune disease (systemic) NOS (M35.9) (from D68)
- certain conditions originating in the perinatal period (P00-P96) (from D68)
- complications of pregnancy, childbirth and the puerperium (O00-O9A) (from D68)
- congenital malformations, deformations and chromosomal abnormalities (Q00-Q99) (from D68)
- endocrine, nutritional and metabolic diseases (E00-E88) (from D68)
- human immunodeficiency virus [HIV] disease (B20) (from D68)
- injury, poisoning and certain other consequences of external causes (S00-T88) (from D68)
- neoplasms (C00-D49) (from D68)
- symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R94) (from D68)
- coagulation defects complicating abortion or ectopic or molar pregnancy (O00-O07, O08.1) (from D68)
- coagulation defects complicating pregnancy, childbirth and the puerperium (O45.0, O46.0, O67.0, O72.3) (from D68)
Also known as
- Antithromboplastinemia
- Antithromboplastinogenemia
- Hemorrhagic disorder due to intrinsic increase in antithrombin
- Hemorrhagic disorder due to intrinsic increase in anti-VIIIa
- Hemorrhagic disorder due to intrinsic increase in anti-IXa
- Hemorrhagic disorder due to intrinsic increase in anti-XIa
- Anticoagulant, circulating
- Circulating anticoagulants
Parent code
- D68.31Hemorrhagic disorder due to intrinsic circulating anticoagulants, antibodies, or inhibitorsHeader